Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(40.0%)
Phase 3
2(40.0%)
Early Phase 1
1(20.0%)
5Total
N/A(2)
Phase 3(2)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT07414277Not ApplicableNot Yet Recruiting

CGM for Insulin-Treated T2DM During Post-Discharge Transition

Role: collaborator

NCT07281196Completed

Semaglutide Effects on Sleep Apnea in Patients With Type 2 Diabetes/Obesity and Comorbid Obstructive Sleep Apnea

Role: lead

NCT03764241Phase 3Unknown

Treatment of Post-STEMI Left Ventricular Thrombus With Optimized Anticoagulant

Role: collaborator

NCT05179733Phase 3Unknown

The Efficacy and Safety of ZR2 Versus R-miniCHOP in the Treatment of Unfit or Frail de Novo Diffuse Large B-cell Lymphoma Patients Aged Older Than or Equal to 70 Years

Role: collaborator

NCT05180851Early Phase 1Unknown

Safety and Efficacy of Recombinant Oncolytic Adenovirus L-IFN Injection in Relapsed/Refractory Solid Tumors Clinical Study

Role: lead

NCT05069194Unknown

Study on the Etiology, Risk Factors and Pathogenesis of COPD Based on Clinical Bioinformatics

Role: collaborator

NCT04140552Unknown

Chinese Research Group of Gallbladder Cancer

Role: collaborator

NCT02240901Not ApplicableCompleted

A Multi-center Randomized Clinical Trial About Using LMA or ETI in Elderly Patients

Role: collaborator

All 8 trials loaded